<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Downey Obesity Report &#187; POLICY</title>
	<atom:link href="http://www.downeyobesityreport.com/category/policy/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.downeyobesityreport.com</link>
	<description>No other human condition combines obesity&#039;s prevalence and prejudice; sickness and stigma; death and discrimination.</description>
	<lastBuildDate>Mon, 06 Feb 2012 22:07:48 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1</generator>
		<item>
		<title>Orexigen and FDA Agree on New Study</title>
		<link>http://www.downeyobesityreport.com/2012/02/orexigen-and-fda-agree-on-new-study/</link>
		<comments>http://www.downeyobesityreport.com/2012/02/orexigen-and-fda-agree-on-new-study/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 22:07:39 +0000</pubDate>
		<dc:creator>MorganDowney</dc:creator>
				<category><![CDATA[DAILY DOWNEY]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Federal Government]]></category>
		<category><![CDATA[NEWS]]></category>
		<category><![CDATA[Contrave]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Orexigen Therapeutics]]></category>

		<guid isPermaLink="false">http://www.downeyobesityreport.com/?p=2859</guid>
		<description><![CDATA[Orexigen Therapeutics Inc. has announced that it has reached agreement with the Food and Drug Administration on a new protocol to test for adverse cardiac events for it obesity-fighting compound, Contrave. Orexigen Therapeutics, Inc. &#8211; Press Release]]></description>
		<wfw:commentRss>http://www.downeyobesityreport.com/2012/02/orexigen-and-fda-agree-on-new-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Competitive Food Sales in Schools Not Affect Obesity</title>
		<link>http://www.downeyobesityreport.com/2012/02/competitive-food-sales-in-schools-not-affect-obesity/</link>
		<comments>http://www.downeyobesityreport.com/2012/02/competitive-food-sales-in-schools-not-affect-obesity/#comments</comments>
		<pubDate>Thu, 02 Feb 2012 16:57:22 +0000</pubDate>
		<dc:creator>MorganDowney</dc:creator>
				<category><![CDATA[Childhood Obesity]]></category>
		<category><![CDATA[DAILY DOWNEY]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Food Economics]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[Schools & Children]]></category>
		<category><![CDATA[competitive foods]]></category>
		<category><![CDATA[dietary pattern]]></category>
		<category><![CDATA[school environment and obesity]]></category>

		<guid isPermaLink="false">http://www.downeyobesityreport.com/?p=2847</guid>
		<description><![CDATA[Most US middle and high schools sell soft drinks, candy and chips to their students. These practices have been widely criticized as contributing to childhood and adolescent obesity. However, a new study followed  approximately 19,450 children from fifth to eight grade. Researchers found the children’s weight gain was not associated with the introduction or the [...]]]></description>
		<wfw:commentRss>http://www.downeyobesityreport.com/2012/02/competitive-food-sales-in-schools-not-affect-obesity/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Will ACOs Be Good For Patients With Obesity ?</title>
		<link>http://www.downeyobesityreport.com/2012/02/will-acos-be-good-for-patients-with-obesity/</link>
		<comments>http://www.downeyobesityreport.com/2012/02/will-acos-be-good-for-patients-with-obesity/#comments</comments>
		<pubDate>Thu, 02 Feb 2012 16:35:21 +0000</pubDate>
		<dc:creator>MorganDowney</dc:creator>
				<category><![CDATA[DAILY DOWNEY]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Health Care Reform]]></category>
		<category><![CDATA[Affordable Care Organizations]]></category>

		<guid isPermaLink="false">http://www.downeyobesityreport.com/?p=2837</guid>
		<description><![CDATA[Accountable Care Organizations are predicted to replace health insurers in 20 years, according to 2 prominent health care policy makers, Ezekiel Emanuel and Jeffrey Liebman in the New York Times. The End of Health Insurance Companies &#8211; NYTimes.com.    The authors point to a shrinking market of traditional insurers and the changes coming under health care [...]]]></description>
		<wfw:commentRss>http://www.downeyobesityreport.com/2012/02/will-acos-be-good-for-patients-with-obesity/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NIH Recommends A1c Testing</title>
		<link>http://www.downeyobesityreport.com/2012/01/nih-recommends-a1c-testing/</link>
		<comments>http://www.downeyobesityreport.com/2012/01/nih-recommends-a1c-testing/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 22:33:38 +0000</pubDate>
		<dc:creator>MorganDowney</dc:creator>
				<category><![CDATA[DAILY DOWNEY]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Federal Government]]></category>
		<category><![CDATA[MANAGING OBESITY]]></category>
		<category><![CDATA[A1c testing]]></category>
		<category><![CDATA[National Institutes of Health]]></category>
		<category><![CDATA[Type 2 diabetes]]></category>

		<guid isPermaLink="false">http://www.downeyobesityreport.com/?p=2802</guid>
		<description><![CDATA[The National Institutes of Health has come out for expanded A1c testing. Their press release and fact sheet point out that the A1c test does not require fasting and helps identify diabetes and pre-diabetes. They recommend testing of anyone 45 years old or younger than 45 are overweight, inactive or have at least one risk [...]]]></description>
		<wfw:commentRss>http://www.downeyobesityreport.com/2012/01/nih-recommends-a1c-testing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Obesity In Ireland</title>
		<link>http://www.downeyobesityreport.com/2011/12/obesity-in-ireland/</link>
		<comments>http://www.downeyobesityreport.com/2011/12/obesity-in-ireland/#comments</comments>
		<pubDate>Wed, 28 Dec 2011 22:09:50 +0000</pubDate>
		<dc:creator>MorganDowney</dc:creator>
				<category><![CDATA[DAILY DOWNEY]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[POLICY]]></category>
		<category><![CDATA[Ireland]]></category>

		<guid isPermaLink="false">http://www.downeyobesityreport.com/?p=2782</guid>
		<description><![CDATA[Obesity is a problem in Ireland with a prevalence similar to that of the United Kingdom and northern Europe.  On our trip this summer, my wife and I could not help looking for the similarities and differences in the approaches to obesity between our two countries. This exercise was more than just a bus man’s [...]]]></description>
		<wfw:commentRss>http://www.downeyobesityreport.com/2011/12/obesity-in-ireland/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Allergan Slapped on Marketing Lap-Band</title>
		<link>http://www.downeyobesityreport.com/2011/12/allergan-slapped-on-marketing-lap-band/</link>
		<comments>http://www.downeyobesityreport.com/2011/12/allergan-slapped-on-marketing-lap-band/#comments</comments>
		<pubDate>Tue, 27 Dec 2011 23:23:02 +0000</pubDate>
		<dc:creator>MorganDowney</dc:creator>
				<category><![CDATA[Bariatric Surgery]]></category>
		<category><![CDATA[DAILY DOWNEY]]></category>
		<category><![CDATA[Federal Government]]></category>
		<category><![CDATA[Allergan]]></category>
		<category><![CDATA[Lap-Band]]></category>
		<category><![CDATA[marketing]]></category>

		<guid isPermaLink="false">http://www.downeyobesityreport.com/?p=2770</guid>
		<description><![CDATA[After the FDA slapped Allergan for the marketing campaign of one of its vendors,  2011 &#62; 1 800 Get Thin LLC 12/12/11, the Los Angeles Times took on Allergan to do step up to the real work of corporate responsibility. Lap-Band maker needs to step up &#8211; Los Angeles Times. A lot of health care [...]]]></description>
		<wfw:commentRss>http://www.downeyobesityreport.com/2011/12/allergan-slapped-on-marketing-lap-band/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Who Would Have Thought?</title>
		<link>http://www.downeyobesityreport.com/2011/12/who-would-have-thought/</link>
		<comments>http://www.downeyobesityreport.com/2011/12/who-would-have-thought/#comments</comments>
		<pubDate>Tue, 27 Dec 2011 22:58:55 +0000</pubDate>
		<dc:creator>MorganDowney</dc:creator>
				<category><![CDATA[DAILY DOWNEY]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Food Economics]]></category>
		<category><![CDATA[Schools & Children]]></category>

		<guid isPermaLink="false">http://www.downeyobesityreport.com/?p=2761</guid>
		<description><![CDATA[Gee, teen-agers want to eat junk food? Eating advice of experts and parents rejected? No way, right? Well, if you were skeptical before about school meal reforms, this article will be right up your alley. It shows the ‘creativity’ of teenagers in frustrating the nutritional advice of adults.  L.A. schools&#8217; healthful school lunches panned by [...]]]></description>
		<wfw:commentRss>http://www.downeyobesityreport.com/2011/12/who-would-have-thought/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Below the Radar</title>
		<link>http://www.downeyobesityreport.com/2011/12/below-the-radar/</link>
		<comments>http://www.downeyobesityreport.com/2011/12/below-the-radar/#comments</comments>
		<pubDate>Fri, 23 Dec 2011 23:06:53 +0000</pubDate>
		<dc:creator>MorganDowney</dc:creator>
				<category><![CDATA[DAILY DOWNEY]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Federal Government]]></category>
		<category><![CDATA[RESEARCH]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Francis Collins]]></category>
		<category><![CDATA[National Institutes of Health]]></category>
		<category><![CDATA[NCATS]]></category>
		<category><![CDATA[translational research]]></category>

		<guid isPermaLink="false">http://www.downeyobesityreport.com/?p=2736</guid>
		<description><![CDATA[Before leaving for his holiday in Hawaii, President Barack Obama signed the appropriations bill to keep the government running. Included in the bill is a provision establishing the National Center for Advancing Translational Sciences (NCATS). This center is the brainchild of NIH Director Francis Collins. Statement by NIH Director Dr. Francis Collins &#8211; NIH Launches [...]]]></description>
		<wfw:commentRss>http://www.downeyobesityreport.com/2011/12/below-the-radar/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vivus Inc. Announces Date for FDA AdCom; results of birth defect study</title>
		<link>http://www.downeyobesityreport.com/2011/12/vivus-inc-announces-date-for-fda-adcom-results-of-birth-defect-study/</link>
		<comments>http://www.downeyobesityreport.com/2011/12/vivus-inc-announces-date-for-fda-adcom-results-of-birth-defect-study/#comments</comments>
		<pubDate>Fri, 23 Dec 2011 21:07:32 +0000</pubDate>
		<dc:creator>MorganDowney</dc:creator>
				<category><![CDATA[DAILY DOWNEY]]></category>
		<category><![CDATA[Drug Therapy]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Federal Government]]></category>
		<category><![CDATA[birth defects]]></category>
		<category><![CDATA[Qnexa]]></category>
		<category><![CDATA[Topiramate]]></category>
		<category><![CDATA[Vivus Inc]]></category>

		<guid isPermaLink="false">http://www.downeyobesityreport.com/?p=2724</guid>
		<description><![CDATA[Vivus Inc. has announced that the FDA will hold an   Advisory Committee meeting on February 22, 2012 for review of the obesity treatment, Qnexa. VIVUS, Inc. &#8211; VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of ObesityTwo days ago, Vivus Inc. released resulted of the FORTRESS study.  The study looked [...]]]></description>
		<wfw:commentRss>http://www.downeyobesityreport.com/2011/12/vivus-inc-announces-date-for-fda-adcom-results-of-birth-defect-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Obama Administration Punts on Essential Benefits</title>
		<link>http://www.downeyobesityreport.com/2011/12/obama-administration-punts-on-essential-benefits/</link>
		<comments>http://www.downeyobesityreport.com/2011/12/obama-administration-punts-on-essential-benefits/#comments</comments>
		<pubDate>Sat, 17 Dec 2011 16:22:16 +0000</pubDate>
		<dc:creator>MorganDowney</dc:creator>
				<category><![CDATA[DAILY DOWNEY]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Health Care Reform]]></category>

		<guid isPermaLink="false">http://www.downeyobesityreport.com/?p=2703</guid>
		<description><![CDATA[The Obama Administration has decided to provide states with wide latitude on defining what constitute “essential benefits” under the Affordable Care Act. This action is sure to be controversial. On the one hand, it avoids political trouble for the Administration to rule certain services in or out of the state exchanges in an election year. [...]]]></description>
		<wfw:commentRss>http://www.downeyobesityreport.com/2011/12/obama-administration-punts-on-essential-benefits/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

